As marijuana gains recognition for having healing properties, the research into how it can help people treat illnesses continues. Now, Cook Children’s Medical Center In Fort Worth, Texas has joined an international drug trial to test a marijuana compound when used to treat epilepsy.
Doctors at the hospital are experimenting with cannabidiol, known as CBD oil, a compound in cannabis that doesn’t get you high, like the THC compound. It is precisely the cannabidiol CBD that has shown positive results in treating seizure activity.
It is considered by the federal government to be a Schedule I drug however.
There are ten participants in the study, children ages two to 14, who have a debilitating form of epilepsy called Lennox-Gastaut Syndrome, or LGS, which causes them to suffer up to 150 seizures a day.
This study marks the first time the FDA has considered cannabis to have any medical value. The results from this study could change the way marijuana is currently viewed by the federal government as a Schedule 1 drug without medical properties.
Hopefully, the children volunteering for the trial will receive benefits from the cannabis treatment.
Below is a video of the youngest baby to receive cannabis oil treatment for epilepsy, though it is a part of the same medical cannabis trial: